Drug Week
Susan Hasty, Publisher
Table of Contents . . . August 18th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
Anti-Cancer Agents - Some Drugs are Cancer Killers by Accident, Not Design
Drug Development - Two Research Grants Awarded for Antibiotic Development
Psoriasis - Enbrel Shows Promise for Treatment of Psoriatic Arthritis
Drug Development - Compound May Hold Promise as Anti-Tumor Agent in Ovarian and Pancreatic Cancer
Head and Neck Cancer - Human Monoclonal Antibody-Based Treatment Results Reported
AIDS Therapies - Certain Chemokines May Be Natural Antivirals
Alzheimer's Disease - Reminyl Receives Approvable Letter from FDA
Antifungals - NSERC to Fund Collaborative Genomics Research
Antiviral Therapies - Experimental Anti-Cancer Drug Also Has Anti-HIV Properties
Attention Deficit Hyperactivity Disorder - No Provigil Benefit Reported in Study of Adults
Cancer Therapies - Beta LT Clinical Trials: Early Termination Due to Positive Results
Cancer Therapies - Completion of Phase I Testing with Declopramide Announced
Drug Development - Neuroprotective Drug Candidate Completes Phase I Single Escalating Dose Study
Drug Development - Peruvian Plants Inhibit Growth of Mycobacterium tuberculosis
Drug Manufacturing - Cheaper, "Greener" Process Developed for Making Cephalosporin-Based Antibiotics
Gastric/Disgestive Disorders - U.K. Medicines Control Agency Announces Withdrawal of Cisapride
Head and Neck Cancer - Multikine Stimulates Effective Immune Response in Clinical Trials
Head and Neck Cancer - Promising Results Announced for Foscan-Mediated Photodynamic Therapy
Herpes Simplex Virus - Docosanol Might Enhance Activity of Current Antiviral Agents
Industry News - Patent Received for Aminosterol in Treatment of Obesity
Industry News - Patents for Thalidomide Analog Issued
Industry News - Two Licensing Agreements Expand Drug Discovery Efforts
Lung Cancer - Patient Enrollment Completed for Tumor Oxygenation Drug
Marketing - Involving Physicians in Clinical Trials Increases Chance They'll Prescribe Drugs
Ophthalmology - FDA Approves Rescula for Glaucoma
Pharmacogenomics - DNA Sciences Launches Web-Based Gene Project
Therapy (HBV) - Famciclovir Dosage for Hepatitis B Patients Optimized
Type 2 Diabetes - Drug Candidate Identified that Inhibits PTP-1B Gene
Type 2 Diabetes - Repaglinide/Troglitazone Combination Therapy Effective
West Nile Virus - NIH Awards Company $3 Million to Develop Vaccine
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
